北美择期无并发症颈动脉内膜切除术后住院时长的区域差异
基于VQI数据库2012-2017年18个区域294个中心36,004例择期无并发症CEA患者,发现24%患者术后住院超过1天,区域和中心独立影响住院时长并解释18%变异,临床因素解释32%变异。
要点
- 择期无并发症CEA后24%患者住院超过1天,区域和中心因素独立解释18%的住院时长变异。
- 术后非家庭出院、使用静脉血管活性药物、术中引流和女性与更长住院时长相关。
- 术前阿司匹林、他汀、高手术量术者和CEA后完成评估与住院≤1天相关。
核心结论
- 择期无并发症CEA后住院时长存在显著区域差异,即使控制多种重要因素后仍存在,提示某些区域有未测量的延长住院原因。
- 改变某些临床实践可能缩短总体住院时长。
研究设计与样本
- 回顾性队列研究,数据来自Vascular Quality Initiative数据库,纳入2012-2017年北美18个区域294个中心36,004例择期无并发症CEA且数据完整的患者。
- 主要结局为术后住院超过1天(LOS >1 POD)。
- 采用LASSO回归、多变量建模和混合效应一般线性模型分析区域差异是否独立于人口学、临床或中心相关因素。
主要发现
- 平均术后住院时长为1.6 ± 6.6天,24%患者LOS >1 POD。
- 区域和中心解释18%的LOS变异,人口学、临床和手术因素解释另外32%的变异。
- 术后非家庭出院(OR 6.3,95%CI 5.2-7.6)、使用静脉血管活性药物(OR 3.2,95%CI 3-3.4)、术中放置引流(OR 1.4,95%CI 1.3-1.55)和女性(OR 1.4,95%CI 1.3-1.5)与更长LOS相关。
- 术前阿司匹林(OR 0.88,95%CI 0.8-0.96)、他汀使用(OR 0.9,95%CI 0.83-0.98)、高手术量术者(最高四分位:OR 0.68,95%CI 0.5-0.87)和CEA后完成评估(如多普勒、超声;OR 0.87,95%CI 0.8-0.95)与LOS ≤1 POD相关。
- 静脉血管活性药物的使用在不同区域间差异显著,且独立于人口学和临床因素。
临床怎么用
- 关注区域和中心层面的因素对CEA术后住院时长的影响,识别可优化的临床实践。
- 对于使用静脉血管活性药物、术中放置引流、女性及术后非家庭出院的患者,预期可能延长住院。
- 鼓励术前使用阿司匹林和他汀、由高手术量术者手术及CEA后完成评估以可能缩短住院。
局限性
- 区域和中心因素仅解释18%的LOS变异,提示存在未测量的延长住院原因。
- 静脉血管活性药物使用区域差异的原因需进一步分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate factors affecting regional variation in length of stay (LOS) after elective, uncomplicated carotid endarterectomy (CEA). METHODS: Data were obtained from the Vascular Quality Initiative database and included patients with complete data who received elective CEA without complications between 2012 and 2017 across 18 regions in North America and 294 centers. The main outcome measure was LOS >1 day after surgery (LOS >1 postoperative day [POD]). Using least absolute shrinkage and selection operator regression, multivariable modeling, and mixed-effects general linear modeling, we evaluated whether regional variations in LOS were independent of demographic, clinical, or center-related factors and to what extent these factors accounted for postoperative variation in LOS. RESULTS: A total of 36,004 patients were included. Mean postprocedure LOS was 1.6 ± 6.6 days. Overall, 24% of patients had an LOS >1 POD. After adjustment for important demographic, clinical, and center-related factors, the region in which a patient was treated independently and significantly affected LOS after elective, uncomplicated CEA. Region and center of treatment accounted for 18% of LOS variation. Demographic, clinical, and surgical factors accounted for another 32% of variation in LOS. Of these factors, postoperative discharge to a facility other than home (odds ratio [OR], 6.3; confidence interval [CI], 5.2-7.6), use of intravenous (IV) vasoactive agents (OR, 3.2; CI, 3-3.4), intraoperative drain placement (OR, 1.4; CI, 1.3-1.55), and female sex (OR, 1.4; CI, 1.3-1.5) were associated with longer LOS. Factors associated with LOS ≤1 POD included preoperative aspirin (OR, 0.88; CI, 0.8-0.96) and statin use (OR, 0.9; CI, 0.83-0.98), high surgeon volume (highest quartile: OR, 0.68; CI, 0.5-0.87), and completion evaluation after CEA (eg, Doppler, ultrasound; OR, 0.87; CI, 0.8-0.95). We also found that use of IV vasoactive medications varied significantly across regions, independent of demographic and clinical factors. CONCLUSIONS: Significant regional variation in LOS exists after elective, uncomplicated CEA even after controlling for a wide range of important factors, indicating that there remain unmeasured causes of longer LOS in some regions. Even so, modification of certain clinical practices may reduce overall LOS. Regional differences in use of IV vasoactive medications not driven by clinical factors warrant further analysis, given the strong association with longer LOS.
引用
- Ross EG, Mell MW. Evaluation of regional variations in length of stay after elective, uncomplicated carotid endarterectomy in North America. J Vasc Surg. 2019. PMID: 31280981. doi:10.1016/j.jvs.2019.02.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。